Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

The Coronary Sinus Balloon Pump in STEMI

Study ID: NCT07354035
Start Date: 2026-02-12
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

177

Intervention / Treatment

The coronary sinus balloon pump

Percutaneous Coronary Intervention (PCI)

Sponsor

Shanghai MicroPort Rhythm MedTech Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

FIBROmyalgia: Somatic Tracking and Exercise Program Study

Study ID: NCT06922747
Start Date: 2027-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Group exercising

Somatic tracking

General activity recommendaitons

Sponsor

University of Tromsø

Source: clinicaltrials.gov

Share:
Add to list

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Study ID: NCT07366684
Start Date: 2026-03
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

550

Intervention / Treatment

Percutaneous Coronary Intervention (PCI)

Conservative Medical Therapy

Sponsor

Clinical Center Niš

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Study ID: NCT05976555
Start Date: 2026-03-01
End Date: 2029-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg)

BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)

BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg)

BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg)

Maximum tolerated dose

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Short-term Effects of Broccoli-derived Glucoraphanin on Recovery From Eccentric Muscle Damage

Study ID: NCT07373106
Start Date: 2026-02-15
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

17

Intervention / Treatment

broccoli powder consumption

Placebo (no broccoli-derived bioactives)

Sponsor

Lithuanian Sports University

Source: clinicaltrials.gov

Share:
Add to list

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Study ID: NCT07361484
Start Date: 2026-06-01
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

442

Intervention / Treatment

Plinabulin

Docetaxel

Placebo (matching plinabulin placebo)

Sponsor

BeyondSpring Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

Influence Of A Slope Adaptive Foot On Participation Of Veterans With Lower-Limb Amputations

Study ID: NCT07266077
Start Date: 2026-04-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Fillauer Slope Adaptive Foot

Fillauer Motion Foot SLX

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

Study ID: NCT07352943
Start Date: 2026-08
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

App

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)

Study ID: NCT06799702
Start Date: 2026-08-01
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Telehealth Behavioral Intervention for promoting HIV and HCV care and MOUD among Persons who inject drugs (PWID)

Sponsor

University of Georgia

Source: clinicaltrials.gov

Share:
Add to list

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

Study ID: NCT05326087
Start Date: 2026-06-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

204

Intervention / Treatment

GnRH antagonist

MPA

Sponsor

ShangHai Ji Ai Genetics & IVF Institute

Source: clinicaltrials.gov

Share:
Add to list